Moreover, USP7 inhibitor treatment of primary CLL was associated with increased ubiquitination of endogenous PTEN and consequently PTEN re-localization into the nucleus (Figure 5D and 5E). The gene discussed is USP7; the disease is B-cell chronic lymphocytic leukemia.